FINANCIAL TIMES | The spread of drug resistant bacteria is relentless but there is hope that society can produce the types of innovative products needed to stave off a larger global crisis. This article looks at the economic and scientific challenges of antibacterial product development and cites CARB-X as the world leader in supporting innovative solutions.